pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 322 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Marketed
    luspatercept
    Reblozyl (luspatercept-aamt)
    Anemia Celgene Corp6 cat
  • Marketed
    ensartinib hydrochloride
    Ensacove (ensartinib hydrochloride)
    Non-Small Cell Lung Cancer Xcovery Holdings Inc3 cat
  • Marketed
    zongertinib
    Hernexeos (zongertinib)
    Non-Small Cell Lung Cancer Boehringer Ingelheim Corp2 cat
  • Marketed
← prev
page 3 of 11
next →
131
Pain89
Neurology1
ET-800
HYDROCORTISONE
Adrenal Insufficiency
$ETON Eton Pharmaceuticals, Inc.
3 cat
  • Marketed
    encorafenib
    Braftovi (encorafenib)
    Metastatic Colorectal Cancer Array BioPharma Inc12 cat
  • Marketed
    loncastuximab tesirine
    Zynlonta (loncastuximab tesirine-lpyl)
    Diffuse Large B-Cell Lymphoma$ADCT ADC Therapeutics SA5 cat
  • Marketed
    mogamulizumab
    Poteligeo (mogamulizumab)
    Peripheral T-Cell Lymphomas (PTCL) Kyowa Kirin Co Ltd5 cat
  • Marketed
    IDELALISIB
    IDELALISIB
    Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma)$GILD GILEAD SCIENCES, INC.1 cat
  • Marketed
    (amivantamab + hyaluronidase (human recombinant))
    Rybrevant Faspro ((amivantamab + hyaluronidase-rhu (human recombinant)))
    Recurrent Head And Neck Squamous Cell Carcinoma$JNJ JOHNSON & JOHNSON2 cat
  • Marketed
    etoposide
    Etopophos (etoposide)
    Small-Cell Lung Cancer H2-Pharma LLC1 cat
  • Marketed
    IDARUBICIN HYDROCHLORIDE
    IDARUBICIN HYDROCHLORIDE
    no indication$PFE PFIZER INC15 cat
  • Marketed
    ZOLEDRONIC ACID
    ZOLEDRONIC ACID
    Paget Disease of Bone Avenacy Inc22 cat
  • Marketed
    HYDROCORTISONE SODIUM SUCCINATE
    HYDROCORTISONE SODIUM SUCCINATE
    Giant Cell Arteritis (Temporal Arteritis/Cranial Arteriti… Cipla USA Inc1 cat
  • Marketed
    LENALIDOMIDE
    LENALIDOMIDE
    Follicular Lymphoma Bristol-Myers Squibb Co2 cat
  • Marketed
    EPIRUBICIN HYDROCHLORIDE
    EPIRUBICIN HYDROCHLORIDE
    Breast Cancer$AMRX Amneal Pharmaceuticals, Inc.7 cat
  • Marketed
    lorlatinib
    Lorbrena (lorlatinib)
    Non-Small Cell Lung Cancer$PFE PFIZER INC7 cat
  • Marketed
    vandetanib
    Caprelsa (vandetanib)
    Medullary Thyroid Cancer Genzyme Corp19 cat
  • Marketed
    Imatinib Mesylate Shilpa
    Imatinib Mesylate
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk… Armas Pharmaceuticals Inc46 cat
  • Marketed
    ANAGRELIDE HYDROCHLORIDE
    ANAGRELIDE HYDROCHLORIDE
    Thrombosis Takeda Pharmaceuticals USA Inc3 cat
  • Marketed
    TOREMIFENE CITRATE
    TOREMIFENE CITRATE
    Metastatic Breast Cancer Rising Pharma Holdings Inc2 cat
  • Marketed
    Bortezomib Pfizer
    Bortezomib
    Mantle Cell Lymphoma Hospira Inc1 cat
  • Marketed
    POMALIDOMIDE
    POMALIDOMIDE
    Kaposi Sarcoma Celgene Corp5 cat
  • Marketed
    mosunetuzumab
    Lunsumio Velo (mosunetuzumab-axgb)
    Diffuse Large B-Cell Lymphoma Genentech Inc3 cat
  • Marketed
    DECITABINE
    DECITABINE
    Chronic Myelomonocytic Leukemia (CMML) Mylan Institutional Inc1 cat
  • Marketed
    obinutuzumab
    Gazyva (obinutuzumab)
    Systemic Lupus Erythematosus F. Hoffmann-La Roche Ltd14 cat
  • Marketed
    rucaparib camsylate
    Rubraca (rucaparib camsylate)
    Epithelial Ovarian Cancer pharmaand GmbH9 cat
  • Marketed
    trastuzumab deruxtecan
    Enhertu (fam-trastuzumab deruxtecan-nxki)
    Metastatic Colorectal Cancer Daiichi Sankyo Co Ltd13 cat
  • Marketed
    Alimta
    Alimta (pemetrexed disodium)
    Malignant Pleural Mesothelioma Lilly USA LLC3 cat
  • Marketed
    NILOTINIB
    NILOTINIB
    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Xspray Pharma AB1 cat
  • Marketed
    (abiraterone acetate + niraparib)
    Akeega ((abiraterone acetate + niraparib))
    Metastatic Castration-Resistant Prostate Cancer (mCRPC)$JNJ JOHNSON & JOHNSON2 cat